drugset / Trial / NCT01967498

Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study

NCT01967498

Unknown 52 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of our double-blind, placebo controlled study is to test the hypothesis that montelukast therapy might be associated with improved hearing in certain sub populations of children suffering from OME.

Timeline

Start
2013-11
Primary completion
2015-12
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified